ArticleGeroScience2026
Beyond the linear genome: how reference bias threatens preventive medicine and geroscience.
Article in GeroScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Genotype-first screening compares patient genomes to a standard reference. The GRCh38 linear assembly contains reference minor alleles (RMAs), posing a critical structural vulnerability for automated clinical variant classification. To determine whether RMAs systematically generate false-positive annotations, we conducted an observational case series of 20 healthy adults undergoing preventive genome sequencing. Automated bioinformatic processing was performed using the GRCh38 linear reference to identify "high-impact" variant annotations generated at loci where GRCh38 differs from the population consensus major allele. Among all 20 participants (100%), linear alignment to GRCh38 systematically misclassified functional major alleles as false-positive "high-impact" annotations at three distinct loci (SLC37A4, CIMIP2A, and GPR33). These artifacts occurred solely because analysis software mathematically defined the healthy wild-type state as a deviation from the rare RMA. Cross-referencing with gnomAD confirmed these as population-dominant benign alleles. Furthermore, this inherent reference bias introduces a theoretical risk of false-negative classifications if RMAs mathematically mask true pathogenic variants. Automated pipelines using linear references systematically misclassify healthy alleles as high-impact functional annotations. While downstream population-frequency filters manage false-positive artifacts, this retrospective patching creates an unsustainable bottleneck for population-scale screening. Transitioning to graph-based pangenome references represents a highly promising approach to directly resolve these diagnostic vulnerabilities at the alignment level, though computational and standardization challenges must first be addressed to ensure the accuracy of large-scale aging research.
Indexed as
Identifiers
42501271What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.